Skip to content

Medmarc Insurance

Medmarc Blog (blog.medmarc.com)

Controversies over Diagnostics Renewed

June 28, 2021

Controversies over Diagnostics Renewed The diagnostic test played a vitally important role during the COVID-19 pandemic, but controversy has followed in vitro diagnostics nonetheless. The...

CMS Adds Administrator, Hits Pause on MCIT

June 02, 2021

CMS Adds Administrator, Hits Pause on MCIT The Center for Medicare & Medicaid Services has a new administrator, Chiquita Brooks-LaSure, signaling an end to a leadership void at an agency that is...

FDA Eyes Remote Inspections After COVID

May 17, 2021

The FDA has provided an overview of the impact of the COVID-19 on its inspectional regime for drugs, devices and biologics, which seriously impeded inspections of all but top priority...

Supreme Court Delivers Unanimous Repudiation to FTC

May 04, 2021

The U.S. Supreme Court has ruled in a case involving the Federal Trade Commission regarding limits to the agency’s statutory authority to obtain restitution from defendants in a range of...

FDA Device Notification Rule Withdrawn

April 20, 2021

The FDA has withdrawn a Jan. 15, 2021, rule by the Department of Health and Human Services that had would have exempted more than 80 medium-risk device types from premarket notification...

HHS Suspends SUNSET Rule

March 30, 2021

The Department of Health and Human Services posted notice of suspension of the Securing Updated and Necessary Evaluations Timely (SUNSET) rule, which would have required review of HHS agency...

CMS Suspends MCIT Start Date

March 16, 2021

The Centers for Medicare & Medicaid Services has suspended the effective date for the proposed Medicare coverage program for FDA-designated breakthrough devices, temporarily reversing a program...

FDA Reacts to COVID Mutations

March 11, 2021

The news of novel variants of the SARS-CoV-2 virus triggered a response from across the U.S. federal government, but the impact was perhaps most keenly felt at the FDA, which issued multiple...

FDA Releases Action Plan for AI

February 17, 2021

The FDA announced an action plan for artificial intelligence in mid-January, which comes across largely as a follow-up to a discussion paper the agency posted in April 2019. The plan lays out a...

Biden Administration Revokes Series of Executive Orders

February 01, 2021

The Biden administration has wasted no time in issuing a number of executive orders (EOs), including those that applied a freeze to or revoked a number of orders issued under the Trump...